Considering 30-days investment horizon, Eli Lilly & is expected to generate 0.52 times more return on investment than SanofiAventis. However, Eli Lilly & is 1.92 times less risky than SanofiAventis. It trades about 0.04 of its potential returns per unit of risk. SanofiAventis is currently generating about -0.31 per unit of risk. If you would invest 4,130 in Eli Lilly & on April 26, 2012 and sell it today you would lose (19.00) from holding Eli Lilly & or give up 0.46% of portfolio value over 30 days.
Diversification
Modest diversification
Overlapping area represents amount of risk that can be diversified away by holding Eli Lilly & Co. and SanofiAventis in the same portfolio (assuming nothing else is changed)
99% of all equities and portfolios perform better than Eli Lilly &. Compared with the overall equity markets, risk-adjusted returns on investments in Eli Lilly & are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
